Fixed-Duration or Continuous Therapy in CLL: Trial Says Take Your Pick

(MedPage Today) — ORLANDO — A year of combination therapy for previously untreated chronic lymphocytic leukemia (CLL) patients led to similar outcomes compared with indefinite BTK inhibition with ibrutinib (Imbruvica) alone, an interim analysis…